UniSa - IRIS Institutional Research Information System

PELLECCHIA, Maria Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.999
AS - Asia 6.195
EU - Europa 2.922
SA - Sud America 542
OC - Oceania 83
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.778
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.885
HK - Hong Kong 3.557
SG - Singapore 1.094
CN - Cina 755
IT - Italia 685
UA - Ucraina 519
RU - Federazione Russa 517
BR - Brasile 487
DE - Germania 304
VN - Vietnam 288
IE - Irlanda 283
SE - Svezia 181
TR - Turchia 170
KR - Corea 165
FI - Finlandia 134
GB - Regno Unito 85
CA - Canada 67
IN - India 60
AU - Australia 47
AT - Austria 38
EE - Estonia 38
NZ - Nuova Zelanda 34
NL - Olanda 33
MX - Messico 29
CZ - Repubblica Ceca 28
PL - Polonia 23
FR - Francia 21
AR - Argentina 18
JP - Giappone 16
BD - Bangladesh 12
IL - Israele 11
IQ - Iraq 11
ZA - Sudafrica 11
VE - Venezuela 10
EC - Ecuador 9
JM - Giamaica 9
ES - Italia 8
PK - Pakistan 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
GR - Grecia 5
KE - Kenya 5
NP - Nepal 5
TW - Taiwan 5
CL - Cile 4
MA - Marocco 4
BE - Belgio 3
EG - Egitto 3
JO - Giordania 3
LU - Lussemburgo 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
LB - Libano 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NR - Nauru 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 16.778
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.553
Ann Arbor 1.422
Chandler 730
Princeton 707
Wilmington 661
Jacksonville 658
Singapore 401
Ashburn 288
Dublin 271
Dong Ket 270
Woodbridge 233
Houston 223
Beijing 177
Nanjing 156
Izmir 153
Moscow 144
Andover 141
Boardman 125
Pellezzano 109
Naples 106
Dearborn 93
Salerno 90
Los Angeles 58
Norwalk 56
Düsseldorf 55
Munich 55
Fairfield 54
Nanchang 49
Hebei 46
Shenyang 45
Changsha 44
Redwood City 41
São Paulo 38
Tallinn 38
Jiaxing 36
Dallas 35
Pune 32
Nuremberg 28
Mestre 27
Rome 27
The Dalles 26
New York 22
San Francisco 22
Brno 21
West Jordan 21
Montreal 20
Amsterdam 18
Belo Horizonte 18
Brooklyn 18
Council Bluffs 17
Seattle 17
Turku 17
Warsaw 17
Washington 17
Boston 16
Columbus 16
Tianjin 16
Auckland 15
Milan 15
Rio de Janeiro 14
San Diego 14
Santa Clara 14
Sydney 14
Casoria 13
Helsinki 13
Lecce 13
Atlanta 11
Brasília 11
Cambridge 11
Fort Worth 11
Guangzhou 11
Tokyo 11
Brisbane 10
Lappeenranta 10
Melbourne 10
Pompei 10
Shanghai 10
Stockholm 10
Vienna 10
Campinas 9
Kunming 9
London 9
Ribeirão Preto 9
Wuhan 9
Chennai 8
Chicago 8
Curitiba 8
Jinan 8
Perugia 8
Porto Alegre 8
Carapicuíba 7
Guarulhos 7
Hefei 7
Ottawa 7
Springfield 7
São José dos Campos 7
Assago 6
Bologna 6
Fuzhou 6
Hanoi 6
Totale 12.214
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 995
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles 701
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 646
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 174
Sex Differences in Parkinson’s Disease: From Bench to Bedside 171
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 168
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 166
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 159
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 152
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 144
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 143
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 135
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 130
The natural history of multiple system atrophy: A prospective European cohort study 121
Brain anatomical substrates of mirror movements in Kallmann syndrome. 118
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 117
Increased bilirubin levels in de novo Parkinson's disease 116
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 115
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 112
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 112
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 111
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 109
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy 108
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 108
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 106
Sindromi parkinsoniane 106
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 104
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 103
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 102
The alpha-synuclein gene in multiple system atrophy 101
The accuracy of the arginine growth hormone test in parkinsonism. 100
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 100
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 100
A novel phenotype in an Italian family with a rare progranulin mutation 99
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 99
Gender and non motor fluctuations in Parkinson's disease: A prospective study 99
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 96
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 95
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 95
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 94
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 94
Gender differences in microRNA expression in levodopa-naive PD patients 92
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 92
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 92
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 92
A genome-wide association study in multiple system atrophy 92
The relevance of gender in Parkinson's disease: a review 90
On the relationship between side of onset and cognition in Parkinson disease 90
Quitting smoking: An early non-motor feature of Parkinson's disease? 88
Early MRI findings in acquired hepatocerebral degeneration. 88
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 88
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 88
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 86
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 86
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 86
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 84
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 84
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms 83
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 82
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 82
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 81
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 81
A critique of the second consensus criteria for multiple system atrophy 81
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 80
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features 80
Parkinson’s disease and the spectrum of Lewy body disease 79
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 78
Mutant COQ2 in multiple-system atrophy. 78
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 78
Uric acid relates to dopamine transporter availability in Parkinson's disease. 77
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 77
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 77
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 77
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 76
The European Multiple System Atrophy-Study Group (EMSA-SG) 76
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 76
Paradoxical response to apomorphine in a case of atypical parkinsonism 75
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 75
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 74
Evidenze di efficacia nella riabilitazione della malattia di Parkinson 73
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 73
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 73
Evolution of mild cognitive impairment in Parkinson disease 73
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 72
Diagnostic agreement in patients with psychogenic movement disorders. 72
Postganglionic sudomotor denervation in patients with multiple system atrophy. 72
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 72
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 71
Resting brain networks in patients with Parkinson's disease and freezing of gait 71
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 71
SNCA variants are associated with increased risk for multiple system atrophy 70
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 70
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 70
Neuropsychiatric disorders in Cushing's syndrome 70
Safety and tolerability of growth-hormone therapy in multiple system atrophy 69
Caratteristiche Cliniche 69
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 68
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 68
Health-related quality of life in multiple system atrophy 67
Multiple system atrophy is distinguished from idiopathic Parkinson's disease bythe arginine growth hormone stimulation test 67
Totale 11.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.157 0 95 106 1 154 80 131 14 120 3 131 322
2021/20221.112 5 7 5 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20253.209 147 35 65 158 159 318 418 342 507 303 379 378
2025/20263.931 3.032 899 0 0 0 0 0 0 0 0 0 0
Totale 17.381